본문 바로가기
KERD
논문KCI 등재

알코올성 치매

Alcohol-Related Dementia

0

조회

0

다운로드

2

인용

0

참고문헌

키워드

초록

Chronic alcohol use may have direct or indirect neurotoxic effects on the brain that can lead to cognitive impairment. However, the precise relationship between alcohol and dementia remains unclear. There are several epidemiological studies suggest that the protective effect of light-moderate alcohol drinking in dementia. But obviously the heavy alcohol drinking can lead to brain dam- age and increase the risk of various types of dementia. The clinicopathological issues and criteria regarding so-called ‘alcoholic de- mentia’ remain under debate. Alcohol-induced persisting amnestic disorder, alcohol-induced persisting dementia, and Wernicke- Korsakoff syndrome (thiamine deficiency) may constitute distinct disease entities, but they may also share some common features. Based on this theory, Oslin and colleagues proposed the broader diagnostic scheme and criteria for Alcohol Related Dementia (ARD), which may include cases of Wernicke-Korsakoff syndrome and also other cases of dementia that appear to be alcohol-re- lated. In pathogenesis of the alcoholic dementia, the chronic exposure to ethanol results in the adaptive up-regulation of NMDA re- ceptor sensitivity, which can result in an increased vulnerability to glutamate induced excitotoxicity. Despite the clinical importance of ARD, few medical treatments for ARD have been proposed and studied. Most of all, the gold standard of the treatment in alco- holic dementia is the maintaining abstinence. Some therapeutic trials with cholinesterase inhibitors (donepezil and rivastigmine) and memantine (NMDA receptor antagonist) have been conducted for the patients with Wernicke-Korsakoff syndrome and alco- hol-related dementia, and these studies reported favorable outcomes. Especially memantine can be a more effective agent in the treatment of alcoholic dementia because of anti-craving effect reported in several studies.

Abstract

Chronic alcohol use may have direct or indirect neurotoxic effects on the brain that can lead to cognitive impairment. However, the precise relationship between alcohol and dementia remains unclear. There are several epidemiological studies suggest that the protective effect of light-moderate alcohol drinking in dementia. But obviously the heavy alcohol drinking can lead to brain dam- age and increase the risk of various types of dementia. The clinicopathological issues and criteria regarding so-called ‘alcoholic de- mentia’ remain under debate. Alcohol-induced persisting amnestic disorder, alcohol-induced persisting dementia, and Wernicke- Korsakoff syndrome (thiamine deficiency) may constitute distinct disease entities, but they may also share some common features. Based on this theory, Oslin and colleagues proposed the broader diagnostic scheme and criteria for Alcohol Related Dementia (ARD), which may include cases of Wernicke-Korsakoff syndrome and also other cases of dementia that appear to be alcohol-re- lated. In pathogenesis of the alcoholic dementia, the chronic exposure to ethanol results in the adaptive up-regulation of NMDA re- ceptor sensitivity, which can result in an increased vulnerability to glutamate induced excitotoxicity. Despite the clinical importance of ARD, few medical treatments for ARD have been proposed and studied. Most of all, the gold standard of the treatment in alco- holic dementia is the maintaining abstinence. Some therapeutic trials with cholinesterase inhibitors (donepezil and rivastigmine) and memantine (NMDA receptor antagonist) have been conducted for the patients with Wernicke-Korsakoff syndrome and alco- hol-related dementia, and these studies reported favorable outcomes. Especially memantine can be a more effective agent in the treatment of alcoholic dementia because of anti-craving effect reported in several studies.

참고문헌 (72)

  1. Bates ME, "Neurocognitive impairment associated with alcohol use disorders: implications for treatment", Experimental and Clinical Psychopharmacology, 10, pp.193~212 (2002)
  2. Jarvenpaa T, "Binge drinking in midlife and dementia risk", Epidemiology, 16, pp.766~771 (2005)
  3. Thomas VS, "Alcohol abuse, cognitive impairment, and mortality among older people", Journal of the American Geriatrics Society, 49, pp.415~420 (2001)
  4. Gupta S, "Alcohol related dementia: a 21st-century silent epidemic", Brit J Psychiatry, 193, pp.351~353 (2008)
  5. Carlen PL, "Alcohol-related dementia in the institutionalized elderly", Alcohol Clin Exp Res, 18, pp.1330~1334 (1994)
  6. Marcos A., "Prevalence of Alcohol-Related Problems in an Elderly Population and Their Association With Cognitive Impairment and Dementia", Alcohol Clin Exp Res, 34, pp.726~733 (2010)
  7. Kim KW, "A Nationwide Survey on the Prevalence of Dementia and Mild Cognitive Impairment in South Korea", JOURNAL OF ALZHEIMERS DISEASE, 23(2), pp.279~289 (2011), IOS PRESS
  8. Butters, N, "The Wernicke-Korsakoff syndrome: a review of psychological, neuropathological and etiological factors", Curr. Alcohol, 8, pp.205~232 (1981)
  9. Harper C, "The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain", Journal of Neuropathology and Experimental Neurology, 57, pp.101~110 (1998)
  10. Sechi G, "Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management", Lancet Neurol, 6, pp.442~455 (2007)
  11. Moriyama Y, "Primary alcoholic dementia and alcohol-related dementia", Psychogeriatrics, 6, pp.114~118 (2006)
  12. Oslin DW, "Alcohol-Related Dementia: Validation of Diagnostic Criteria", Am J Geriatr Psychiatry, 11, pp.441~447 (2003)
  13. Oslin D, "Alcohol related dementia: proposed clinical criteria", Int J Geriatr Psychiatry, 13, pp.203~212 (1998)
  14. Sher L, "Wernicke-Korsakoff syndrome and alcohol-induced persistent dementia", Australian & New Zealand Journal of Psychiatry, 38, pp.976~977 (2004)
  15. Gupta S, "Alcohol-related dementia: a 21st-century silent epidemic", The British Journal of Psychiatry, 193, pp.351~353 (2008)
  16. Hulse GK, "Dementia associated with alcohol and other drug use", Int Psychogeriatr, 17(Suppl 1), pp.S109~S127 (2005)
  17. Mukamal KJ, "Prospective study of alcohol consumption and risk of dementia in older adults", JAMA, 289, pp.1405~1413 (2003)
  18. Weyerer S, "German AgeCoDe Study group (German Study on Ageing, Cognition and Dementia in Primary Care Patients). Current alcohol consumption and its relationship to incident dementia: results from a 3-year follow- up study among primary care attenders aged 75 years and older", Age Ageing, 40, pp.456~463 (2011)
  19. Lindsay J, "Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian study of health and aging", Am J Epidemiol, 156, pp.445~453 (2002)
  20. Ruitenberg A, "Alcohol consumption and risk of dementia: the Rotterdam study", Lancet, 359, pp.281~286 (2002)
  21. Cervilla JA, "Smoking, drinking and incident cognitive impairment: a cohort community based study included in the Gospel Oak project", J Neurol Neurosurg Psychiatry, 68, pp.622~626 (2000)
  22. Smith DM, "Alcoholism and dementia", The International Journal of the Addictions, 30, pp.1843~1869 (1995)
  23. Harper CG, "Ethanol and brain damage", Current Opinion in Pharmacology, 5, pp.73~78 (2005)
  24. Rehm J, "Are lifetime abstainers the best control group in alcohol epidemiology? On the stability and validity of reported lifetime abstention", Am J Epidemiol, 168, pp.866~871 (2008)
  25. Peters R, "Alcohol, dementia and cognitive decline in the elderly: a systematic review", Age Ageing, 37, pp.505~512 (2008)
  26. Lobo E, "Is There an Association Between Low-to-Moderate Alcohol Consumption and Risk of Cognitive Decline", Am J Epidemiol, 172, pp.708~716 (2010)
  27. Anttila T, "Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study", BMJ, 329, pp.539~ (2004)
  28. Paul CA, "Association of alcohol consumption with brain volume in the Framingham study", Arch Neurol, 65, pp.1363~1367 (2008)
  29. Ganguli M, "Alcohol consumption and cognitive function in late life: a longitudinal community study", Neurology, 65, pp.1210~1217 (2005)
  30. Panza F, "Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective", Int J Geriatr Psychiatry (2012)[DOI]
  31. Rimm EB, "Alcohol and coronary heart disease: drinking patterns and mediators of effect", Ann Epidemiol, 17, pp.S3~S7 (2007)
  32. Järvenpää T, "Binge drinking in midlife and dementia risk", Epidemiology, 16, pp.766~771 (2005)
  33. Natalie M. Zahr, "Clinical and pathological features of alcohol-related brain damage", Nat Rev Neurol, 7, pp.284~294 (2011)
  34. Nakamura K, "Acetaldehyde adducts in the brain of alcoholics", Arch. Toxicol, 77, pp.591~593 (2003)
  35. Brooks PJ, "Brain atrophy and neuronal loss in alcoholism: a role for DNA damage", Neurochem Int, 37, pp.403~412 (2000)
  36. Climent E, "Ethanol exposure enhances cell death in the developing cerebral cortex: role of brain-derived neurotrophic factor and its signaling pathways", J Neurosci Res, 68, pp.213~225 (2002)
  37. Verbaten MN, "Chronic effects of low to moderate alcohol consumption on structural and functional properties of the brain: beneficial or not", Hum Psychopharmacol, 24, pp.199~205 (2009)
  38. Jee Wook Kim, "Alcohol and Cognition in the Elderly: A Review", PSYCHIATRY INVESTIGATION, 9(1), pp.8~16 (2012), 대한신경정신의학회
  39. Harper CG, "The neurotoxicity of alcohol", Human & Experimental Toxicology, 26, pp.251~257 (2007)
  40. Sullivan EV, "Hippocampal volume deficits in alcoholic Korsakoff’s Syndrome", Neurology, 61, pp.1716~1719 (2003)
  41. Harding AJ, "Loss of vasopressin- immunoreactive neurons in alcoholics is dose-related and timedependent", Neuroscience, 72, pp.699~708 (1996)
  42. Rosenbloom MJ, "Recovery of shortterm memory and psychomotor speed but not postural stability with long-term sobriety in alcoholic women", Neuropsychology, 18, pp.589~597 (2004)
  43. Fein G, "Cognitive performance in longterm abstinent alcoholic individuals", Alcoholism: Clinical and Experimental Research, 30, pp.1538~1544 (2006)
  44. Butterworth RF, "Hepatic encephalopathy-a serious complication of alcoholic liver disease", Alcohol Res Health, 27, pp.143~145 (2003)
  45. Mahley RW, "Is epsilon4 the ancestral human apoE allele", Neurobiol Aging, 20, pp.429~430 (1999)
  46. Harper CG, "Clinical signs in the Wernicke- Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy", J. Neurol. Neurosurg. Psychiatry, 49, pp.341~345 (1986)
  47. Caine D, "Operational criteria for the classification of chronic alcoholics: identification of Wernicke’s encephalopathy", J Neurol Neurosurg Psychiatry, 2, pp.51~60 (1997)
  48. Galvin R, "EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy", Eur J Neurol, 17, pp.1408~1418 (2010)
  49. Schmidt KS, "The neuropsychological profile of alcohol-related dementia suggests cortical and subcortical pathology", Dementia and Geriatric Cognitive Disorders, 20, pp.286~291 (2005)
  50. Mann K, "Rapid recovery from cognitive deficits in abstinent alcoholics: A controlled test-retest study", Alcohol Alcohol, 34, pp.567~574 (1999)
  51. Eckardt MJ, "Neuropsychological functioning in detoxified alcoholics between 18 and 35 years of age", Am J Psychiatry, 152, pp.53~59 (1995)
  52. Gazdzinski S, "Temporal dynamics and determinants of whole brain tissue volume changes during recovery from alcohol dependence", Drug Alcohol Depend, 8, pp.263~273 (2005)
  53. Gansler DA, "Hypoperfusion of inferior frontal brain regions in abstinent alcoholics: A pilot SPECT study", Journal of Studies on Alcohol, 61, pp.32~37 (2000)
  54. Preuss UW, "Memantine treatment in alcohol dementia: rapid PET changes and clinical course", Eur Neurol, 45, pp.57~58 (2001)
  55. Bartels C, "Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence", Alcohol Alcohol, 42, pp.92~102 (2007)
  56. Iga JI, "A case of Korsakoff’s syndrome improved by high doses of donepezill", Alcohol Alcohol, 36(6), pp.553~555 (2001)
  57. Casadevall-Codina T, "Pharmacological treatment of Korsakoff’s psychosis: a review of the literature and experience in two cases", Rev Neurol, 35, pp.341~345 (2002)
  58. Cochrane M, "Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome--three further cases show response to donepezil", Alcohol Alcohol, 40, pp.151~154 (2005)
  59. Angunawela II, "Anticholinesterase drugs for alcoholic Korsakoff syndrome", Int J Geriatr Psychiatry, 16, pp.338~339 (2001)
  60. Kim KY, "Donepezil for alcohol-related dementia: a case report", Pharmacotherapy, 24, pp.419~421 (2004)
  61. Gibson RC, "Rivastigmine in the treatment of alcohol-in-duced persisting dementia", West Indian Med J, 52, pp.59~61 (2003)
  62. Kornhuber J, "Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy", Biological Psychiatry, 41, pp.135~144 (1997)
  63. Muller WE, "Noncompetitive NMDA receptor antagonist with fast open-channel blocking kinetics and strong voltage dependency as potential therapeutic agents for Alzheimer’s dementia", Pharmacopsychiatry, 28, pp.113~124 (1995)
  64. Parsons CG, "Memantine is a clinically well to-lerated NMDA receptor antagonist -a review of preclinical data", Neu-ropsychopharmacology, 38, pp.735~767 (1999)
  65. Holter SM, "Evidence for alcohol anti-craving properties of memantine", European Journal of Pharmacology, 314, pp.R1~R2 (1996)
  66. Lukoyanov NV, "Memantine, but not dizocilpine, ameliorates cognitive deficits in adult rats withdrawn from chronic ingestion of alcohol", Neuroscience Letters, 309, pp.45~48 (2001)
  67. Maler JM, "Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons", Brain Research, 1052, pp.156~162 (2005)
  68. Bisaga A, "Acute effects of memantine in combination with alcohol in moderate drinkers", Psychopharmacology (Berl), 172, pp.16~24 (2004)
  69. Krupitsky EM, "Ef-fect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients", Am J Psychiatry, 164, pp.519~523 (2007)
  70. Rustembegovic A, "A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome", Med Arh, 57, pp.149~150 (2003)
  71. Preuss UW, "Memantine treatment in alcohol dementia: rapid PET changes and cli-nical course", Eur Neurol, 45, pp.57~58 (2001)
  72. Cheon Y, "The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia", Int J Neuropsychopharmacol, 11, pp.971~983 (2008)

관련 논문AI추천

이 간행물의 다른 논문 (7건)